Is there a role for intravenous iron therapy in patients undergoing colorectal cancer resection?

References

• Weber RS, Jabbour N, Martin RC 2nd. Anemia and transfusions in patients undergoing surgery for cancer. Ann. Surg. Oncol. 15(1), 34–45 (2008).
   Google Scholar
• Maxwell MJ, Wilson MJA. Complications of blood transfusion. Contin. Educ. Anaesth. Crit. Care Pain 6(6), 225–229 (2006).
   Google Scholar
• Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann. Surg. 256(2), 235–244 (2012).
   PubMed Web of Science ®Google Scholar
• Dicato M. Venous thromboembolic events and erythropoiesis-stimulating agents: an update. Oncologist 13(Suppl. 3), 11–15 (2008).
   Google Scholar
• Henke M, Laszig R, Rübe C et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362(9392), 1255–1260 (2003).
   PubMed Web of Science ®Google Scholar
• Henke M, Mattern D, Pepe M et al. Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J. Clin. Oncol. 24(29), 4708–4713 (2006).
   PubMed Web of Science ®Google Scholar
• Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102(3), 783–788 (2003).
   PubMed Web of Science ®Google Scholar
• Gasche C, Berstad A, Befrits R et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm. Bowel Dis. 13(12), 1545–1553 (2007).
   PubMed Web of Science ®Google Scholar
• Titos-Arcos JC, Soria-Aledo V, Carrillo-Alcaraz A, Ventura-López M, Palacios-Muñoz S, Pellicer-Franco E. Is intravenous iron useful for reducing transfusions in surgically treated colorectal cancer patients? World J. Surg. 36(8), 1893–1897 (2012).
   PubMed Web of Science ®Google Scholar
• Hébert PC, Wells G, Blajchman MA et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N. Engl. J. Med. 340(6), 409–417 (1999).
   PubMed Web of Science ®Google Scholar
• McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993–2005. Public Health Nutr. 12(4), 444–454 (2009).
   PubMed Web of Science ®Google Scholar
• Jakobsen EB, Eickhoff JH, Andersen J, Lundvall L, Stenderup JK. Perioperative blood transfusion and recurrence and death after resection for cancer of the colon and rectum. Scand. J. Gastroenterol. 25(5), 435–442 (1990).
   PubMed Web of Science ®Google Scholar
• Giannoulis C, Daniilidis A, Tantanasis T, Dinas K, Tzafettas J. Intravenous administration of iron sucrose for treating anemia in postpartum women. Hippokratia 13(1), 38–40 (2009).
   PubMed Web of Science ®Google Scholar
• Lindgren S, Wikman O, Befrits R et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand. J. Gastroenterol. 44(7), 838–845 (2009).
   PubMed Web of Science ®Google Scholar
• Li H, Wang SX. Intravenous iron sucrose in peritoneal dialysis patients with renal anemia. Perit. Dial. Int. 28(2), 149–154 (2008).
   Google Scholar
• Evstatiev R, Marteau P, Iqbal T et al.; FERGI Study Group. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 141(3), 846–853.e1 (2011).
   PubMed Web of Science ®Google Scholar
• Ward DG, Roberts K, Brookes MJ et al. Increased hepcidin expression in colorectal carcinogenesis. World J. Gastroenterol. 14(9), 1339–1345 (2008).
   PubMed Web of Science ®Google Scholar
• Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101(7), 2461–2463 (2003).
   PubMed Web of Science ®Google Scholar
• Nemeth E, Tuttle MS, Powelson J et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704), 2090–2093 (2004).
   PubMed Web of Science ®Google Scholar
• Ludwig H, Van Belle S, Barrett-Lee P et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur. J. Cancer 40(15), 2293–2306 (2004).
   PubMed Web of Science ®Google Scholar
• Leichtle SW, Mouawad NJ, Lampman R, Singal B, Cleary RK. Does preoperative anemia adversely affect colon and rectal surgery outcomes? J. Am. Coll. Surg. 212(2), 187–194 (2011).
   PubMed Web of Science ®Google Scholar
• Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 110(3), 574–581 (2009).
   Google Scholar
• Kulnigg S, Stoinov S, Simanenkov V et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am. J. Gastroenterol. 103(5), 1182–1192 (2008).
   PubMed Web of Science ®Google Scholar
• Anker SD, Comin Colet J, Filippatos G et al.; FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med. 361(25), 2436–2448 (2009).
   PubMed Web of Science ®Google Scholar
• Okonko DO, Grzeslo A, Witkowski T et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J. Am. Coll. Cardiol. 51(2), 103–112 (2008).
   PubMed Web of Science ®Google Scholar
• Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int. J. Gynaecol. Obstet. 101(1), 67–73 (2008).
   PubMed Web of Science ®Google Scholar
• Simpson JAD, Ng SL, Brookes MJ, Acheson AG. Single dose preoperative administration of intravenous iron corrects iron deficiency anaemia in colorectal cancer. J. Blood Dis. Transfusion 1(101), 1–4 (2010).
   Google Scholar
• Edwards TJ, Noble EJ, Durran A, Mellor N, Hosie KB. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. Br. J. Surg. 96(10), 1122–1128 (2009).
   Google Scholar
• Lidder PG, Sanders G, Whitehead E et al. Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery – a prospective, randomised, controlled trial. Ann. R. Coll. Surg. Engl. 89(4), 418–421 (2007).
   Google Scholar
• Quinn M, Drummond RJ, Ross F, Murray J, Murphy J, Macdonald A. Short course pre-operative ferrous sulphate supplementation – is it worthwhile in patients with colorectal cancer? Ann. R. Coll. Surg. Engl. 92(7), 569–572 (2010).
   PubMedGoogle Scholar